Sidero Biosciences, LLC (Sidero) is dedicated to providing a safe, effective, and economical iron therapy to alleviate iron deficiency for all peoples of the world. Sidero is a clinical stage biotechnology company advancing technologies targeting human nutritional health. Our technologies utilize the SideroSorb platform, to orally deliver beneficial proteins/complexes to ameliorate human disease.
Our latest innovation, BioFe, is an oral iron supplement that targets iron deficiencies through a new uptake mechanism. This mechanism mimics the body's natural pathway as found in the transporting of iron through the umbilical cord and breast feeding. This pathways minimizes GI distress other iron supplements tend to produce.
Sidero is poised to rapidly advance a market launch with BioFe.